SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?


To: Jenna who wrote (8718)4/29/1998 3:45:00 PM
From: Jenna  Respond to of 120523
 
(JAII .O) Q1 DIL SHR PROFIT $1.40 VS LOSS $0.19 OTEXF: picked up some May 20's this afternoon. Sells: WAXS, RCL holding HOT, JAII...

OPEN TEXT:...
OTEXF.. TORONTO (April 28) BW HEALTHWIRE -April 28, 1998--
Base4 to Resell Livelink Intranet as Part of Value Added Solution to Help Companies Manage Complex Multiyear Discovery and

Development Processes of New Pharmaceuticals and Therapeutics

Base4 Bioinformatics Inc. announced today an agreement with Open Text Corporation to resell Livelink Intranet with its PharMatrix product to create an advanced intranet solution to accelerate the discovery and development of new pharmaceuticals to treat human disease. As a leading provider of integrated systems solutions to pharmaceutical and biotechnology companies, Base4 has become a member of the Livelink Affinity Reseller Program, and will be a value-added reseller of Livelink to its customers across North America.

"A wealth of new opportunities to discover and develop novel and more effective pharmaceuticals have been created by recent technical advances in the industry. However, these new methods in genetics, chemistry and automation are creating an unprecedented flood of data," said Martin Sumner-Smith, President & CEO, Base4 Bioinformatics Inc. "Livelink provides a complete knowledge management solution to manage the data and allow team collaboration between research centres around the world. PharMatrix builds on the solution to meet the specific needs of pharmaceutical discovery."



To: Jenna who wrote (8718)4/29/1998 8:05:00 PM
From: tom pope  Respond to of 120523
 
>>ORBKF.. is one terrific company.. Israeli stocks are usually very undervalued<<

Another two possibly undervalued but certainly underfollowed Israeli stocks are TTILF and FLSHF. FLSHF is a bet that that all the big guns developing flash memory won't trample them; TTILF just keeps winning new contracts and chugging along, having only just about doubled since January, with all of one analyst covering it. Chart is scary, tho.



To: Jenna who wrote (8718)4/29/1998 9:45:00 PM
From: Magnatizer  Read Replies (1) | Respond to of 120523
 
Jenna

I am not sure if the post regarding ORBKF was intended for me but thanks. I own another Israeli stock which I believe you mentioned is in your long term portfolio, TLDCF. Is it still a hold for you? I am a bit concerned over the recent developments with the company. Lots of rumors concerning takeover and no price movement.

ht
david